Enoma 4000 Anti-Xa IU/0.4 ml (SC Injection)
0.4 ml pre-filled syringe: ৳ 400.00
Medicine Details
Category | Details |
---|---|
Generic | Enoxaparin sodium |
Company | Biopharma limited |
Also available as |
Indications
- Treatment of deep vein thrombosis, with or without pulmonary embolism
- Treatment of unstable angina and non-Q-wave myocardial infarction
- Prevention of thrombus formation in the extra-corporal circulation during haemodialysis
- Prophylaxis of venous thromboembolic disease in surgical patients
- Prophylaxis of venous thromboembolic disease in medical patients
Composition
- Each 0.2 ml pre-filled syringe contains Enoxaparin Sodium BP 20 mg
- Each 0.4 ml pre-filled syringe contains Enoxaparin Sodium BP 40 mg
- Each 0.6 ml pre-filled syringe contains Enoxaparin Sodium BP 60 mg
- Each 0.8 ml pre-filled syringe contains Enoxaparin Sodium BP 80 mg
Pharmacology
Low molecular weight heparin with high anti-Xa activity and low anti-lla or antithrombin activity
Dosage
- Subcutaneously 100 anti-Xa lU/kg twice daily for 10 days
- Oral anticoagulant therapy initiation when appropriate
- Subcutaneously 100 anti-Xa lU/kg twice daily for 2-8 days concurrently with oral aspirin
- Recommended dose of 100 anti-Xa lU/kg for prevention of thrombus formation during hemodialysis
- Different doses based on risk for surgical and medical patients
Administration
- Injection site preparation guidelines
- Instructions on selecting and adjusting dose
- Guidelines for injecting and handling used syringes
Interaction
Recommendation to discontinue agents affecting hemostasis prior to therapy
Contraindications
Hypersensitivity to Enoxaparin Sodium, active major bleeding, high risk of uncontrolled hemorrhage
Side Effects
- Haemorrhage (bleeding)
- Thrombocytopenia
- Elevations of serum aminotransferase
- Pain and skin reactions at injection sites
- Cases of neuraxial hematomas with spinal/epidural anesthesia
Pregnancy & Lactation
Pregnancy category B, caution in nursing mothers
Precautions & Warnings
- Administer by deep subcutaneous or intravascular route
- Caution in conditions with increased potential for bleeding
- Recommendation for platelet count measurement
Use in Special Populations
- No dosage adjustment for elderly patients
- Observation for signs of bleeding in renal impairment
- Caution in hepatically impaired patients
Overdose Effects
Accidental overdosage may lead to hemorrhagic complications
Therapeutic Class
Parenteral anti-coagulants
Storage Conditions
Store in a cool and dry place, protect from light and moisture, below 25°C
Related Brands
- Vistarin 6000 Anti-Xa IU/0.6 ml (SC Injection) - aci-limited
- Vistarin 4000 Anti-Xa IU/0.4 ml (SC Injection) - aci-limited
- Claxo 4000 Anti-Xa IU/0.4 ml (SC Injection) - general-pharmaceuticals-ltd
- Noxarin 8000 Anti-Xa IU/0.8 ml (SC Injection) - opsonin-pharma-ltd
- Noxarin 6000 Anti-Xa IU/0.6 ml (SC Injection) - opsonin-pharma-ltd